Andrew Scott

Prof. Scott's current appointments include Laboratory Head, Olivia Newton-John Cancer Research Institute; Professor, School of Cancer Medicine, La Trobe University; Professor, Department of Medicine, University of Melbourne; and Director, Department of Molecular Imaging and Therapy, Austin Hospital, Melbourne, Australia.
Prof. Scott is Chair of the Board of Cancer Trials Australia, and President of the World Federation of Nuclear Medicine and Biology. He is also a Board member of the Australian Nuclear Science and Technology Organisation, and the Victorian Cancer Biobank.
His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies, and in molecular imaging, particularly oncology applications in PET in staging cancer. His laboratory has been involved in the preclinical development and first-in-man trials of eight recombinant antibodies in cancer patients, and five antibodies from his laboratory have been licenced to Biotech and Pharma companies. Prof. Scott has 307 peer reviewed publications reviews and 20 book chapters principally in cancer research and PET. 

Our Sponsors